Monday, September 27, 2021 3:15:46 PM
No I can't. I wrote that in a hurry. Meant that it's generally believed the placebo affect "normalizes" after a period. Not that it's absent. And in some cases with Schizophrenia, for example, it has been shown to increase.
I'm referencing the study design where there IS NO placebo in these open label trials. Like I said EARLIER: It is just a step!
Then we take THE NEXT. Where there will be a placebo & we'll see how she does.
Can anyone show me a drug that performed better to this point without any adverse effects?
138 or so drugs Big Pharma pipelined for AH's & I don't recall seeing ANYTHING better to this 12mo P2T timeframe. Correct me if I'm wrong.
Recent FLNA News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 09:16:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 12:10:21 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:06:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:04:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 08:01:27 PM
